In addition, overexpressed IL-4 and IL-13 receptors on cancer cells are specific targets for receptor-directed cancer immunotherapy74. Our study confirms changes in the Th1/Th2 cytokine profiles of patients with TPE and MPE, which may be helpful for future investigations of cytokine therapies. This evidence concerns the gene IL4 and cancer.